Literature DB >> 30284525

Repeated Chlamydia trachomatis infections are associated with lower bacterial loads.

K Gupta1, R K Bakshi1, B Van Der Pol1, G Daniel1, L Brown1, C G Press1, R Gorwitz2, J Papp2, J Y Lee3, W M Geisler1.   

Abstract

Chlamydia trachomatis (CT) infections remain highly prevalent. CT reinfection occurs frequently within months after treatment, likely contributing to sustaining the high CT infection prevalence. Sparse studies have suggested CT reinfection is associated with a lower organism load, but it is unclear whether CT load at the time of treatment influences CT reinfection risk. In this study, women presenting for treatment of a positive CT screening test were enrolled, treated and returned for 3- and 6-month follow-up visits. CT organism loads were quantified at each visit. We evaluated for an association of CT bacterial load at initial infection with reinfection risk and investigated factors influencing the CT load at baseline and follow-up in those with CT reinfection. We found no association of initial CT load with reinfection risk. We found a significant decrease in the median log10 CT load from baseline to follow-up in those with reinfection (5.6 CT/ml vs. 4.5 CT/ml; P = 0.015). Upon stratification of reinfected subjects based upon presence or absence of a history of CT infections prior to their infection at the baseline visit, we found a significant decline in the CT load from baseline to follow-up (5.7 CT/ml vs. 4.3 CT/ml; P = 0.021) exclusively in patients with a history of CT infections prior to our study. Our findings suggest repeated CT infections may lead to possible development of partial immunity against CT.

Entities:  

Keywords:  Bacterial load; Chlamydia trachomatis; infectious disease; sexually transmitted infections (STIs)

Year:  2018        PMID: 30284525      PMCID: PMC6447480          DOI: 10.1017/S0950268818002704

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

Review 1.  Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.

Authors:  William M Geisler
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis.

Authors:  João P Gomes; Maria J Borrego; Berna Atik; Irene Santo; Jacinta Azevedo; Armando Brito de Sá; Paulo Nogueira; Deborah Dean
Journal:  Microbes Infect       Date:  2005-07-13       Impact factor: 2.700

3.  Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.

Authors:  William M Geisler; Apurva Uniyal; Jeannette Y Lee; Shelly Y Lensing; Shacondra Johnson; Raymond C W Perry; Carmel M Kadrnka; Peter R Kerndt
Journal:  N Engl J Med       Date:  2015-12-24       Impact factor: 91.245

4.  Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.

Authors:  Sandra G Morrison; Christina M Farris; Gail L Sturdevant; William M Whitmire; Richard P Morrison
Journal:  J Infect Dis       Date:  2011-02-14       Impact factor: 5.226

Review 5.  The Epidemiology of Chlamydia trachomatis Organism Load During Genital Infection: A Systematic Review.

Authors:  Lenka A Vodstrcil; Ruthy McIver; Wilhelmina M Huston; Sepehr N Tabrizi; Peter Timms; Jane S Hocking
Journal:  J Infect Dis       Date:  2014-12-09       Impact factor: 5.226

Review 6.  Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature.

Authors:  Christina B Hosenfeld; Kimberly A Workowski; Stuart Berman; Akbar Zaidi; Jeri Dyson; Debra Mosure; Gail Bolan; Heidi M Bauer
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

7.  Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis.

Authors:  B P Katz; B E Batteiger; R B Jones
Journal:  Sex Transm Dis       Date:  1987 Jul-Sep       Impact factor: 2.830

Review 8.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

9.  Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics.

Authors:  Jennifer Walker; Sepehr N Tabrizi; Christopher K Fairley; Marcus Y Chen; Catriona S Bradshaw; Jimmy Twin; Nicole Taylor; Basil Donovan; John M Kaldor; Kathleen McNamee; Eve Urban; Sandra Walker; Marian Currie; Hudson Birden; Francis Bowden; Jane Gunn; Marie Pirotta; Lyle Gurrin; Veerakathy Harindra; Suzanne M Garland; Jane S Hocking
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 10.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.

Authors:  Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

  10 in total
  8 in total

1.  Bacterial Load of Chlamydia trachomatis in the Posterior Oropharynx, Tonsillar Fossae, and Saliva among Men Who Have Sex with Men with Untreated Oropharyngeal Chlamydia.

Authors:  Tiffany R Phillips; Christopher K Fairley; Kate Maddaford; Jennifer Danielewski; Jane S Hocking; David Lee; Deborah A Williamson; Gerald Murray; Fabian Kong; Vesna De Petra; Catriona S Bradshaw; Marcus Y Chen; Rebecca Wigan; Anthony Snow; Benjamin P Howden; Suzanne M Garland; Eric P F Chow
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

2.  The Reaction of Innate Lymphoid Cells in the Mouse Female Genital Tract to Chlamydial Infection.

Authors:  Svenja Barth; Susanne Kirschnek; Noemi Ortmann; Yakup Tanriver; Georg Häcker
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

3.  Chlamydia trachomatis Infection and Seropositivity in Women Reporting Sexual Contact to a Chlamydia-Infected Partner.

Authors:  Kanupriya Gupta; Barbara Van Der Pol; Christen G Press; William M Geisler
Journal:  Sex Transm Dis       Date:  2022-02-08       Impact factor: 3.868

4.  Predicting the Probability of Chlamydia Reinfection in African American Women Using Immunologic and Genetic Determinants in a Bayesian Model.

Authors:  Kristin M Olson; William M Geisler; Rakesh K Bakshi; Kanupriya Gupta; Hemant K Tiwari
Journal:  Sex Transm Dis       Date:  2021-11-01       Impact factor: 2.830

5.  Protection Generated by Prior Exposure to Pathogens Depends on both Priming and Challenge Dose.

Authors:  Chava L Weitzman; Guadalupe Ceja; Ariel E Leon; Dana M Hawley
Journal:  Infect Immun       Date:  2022-01-18       Impact factor: 3.609

6.  Chlamydia trachomatis bacterial load, estimated by Cq values, in urogenital samples from men and women visiting the general practice, hospital or STI clinic.

Authors:  Juliën N A P Wijers; Christian J P A Hoebe; Geneviève A F S van Liere; Petra F G Wolffs; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

Review 7.  Controversies and evidence on Chlamydia testing and treatment in asymptomatic women and men who have sex with men: a narrative review.

Authors:  Nicole H T M Dukers-Muijrers; Ymke J Evers; Christian J P A Hoebe; Petra F G Wolffs; Henry J C de Vries; Bernice Hoenderboom; Marianne A B van der Sande; Janneke Heijne; Jeffrey D Klausner; Jane S Hocking; Jan van Bergen
Journal:  BMC Infect Dis       Date:  2022-03-14       Impact factor: 3.090

8.  Antibodies to Variable Domain 4 Linear Epitopes of the Chlamydia trachomatis Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women.

Authors:  Amanda L Collar; Alexandria C Linville; Susan B Core; Cosette M Wheeler; William M Geisler; David S Peabody; Bryce Chackerian; Kathryn M Frietze
Journal:  mSphere       Date:  2020-09-23       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.